Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth

Novo Nordisk: AWARD-6 is out with no surprises: and now ?

BUY, Fair Value DKK257 vs. DKK245 (-2%)

Published last February Wednesday 26, 2014

Alten: FY13 op. margin slightly above expectations, solid free cash flow

NEUTRAL, Fair Value EUR35 (-4%)

Published last February Wednesday 26, 2014

Atos to sign a long-term agreement with a Russian IT JV

BUY, Fair Value EUR76 (+13%)

Published last February Monday 24, 2014

Sopra Group: Feedback from Paris roadshow

BUY, Fair Value EUR101 (+10%)

Published last February Monday 24, 2014

Atos: FY13 results in line, FY14 guidance a bit light on the margin

BUY, Fair Value EUR76 (+9%)

Published last February Wednesday 19, 2014

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities